Current situation on the availability of nanostructure–biological activity data

SAR and QSAR in Environmental Research

Volumn 26, Issue 2, 2015, Pages 79-94

  Oksel, C ^a   Ma, C Y ^a   Wang, X Z ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

in silico; nano (Q)SAR; nano SAR; nanomaterials; nanotoxicity

Indexed keywords

BIOACTIVITY; COMPUTATIONAL CHEMISTRY; MOLECULAR GRAPHICS; TOXICITY;

CURRENT SITUATION; ENGINEERED NANOMATERIALS; HUMAN HEALTH; IN-SILICO; LITERATURE DATA; NANO-(Q)SAR; NANO-SAR; NANOPRODUCTS; NANOTOXICITY; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP MODELING;

NANOSTRUCTURED MATERIALS;

NANOMATERIAL;

CHEMISTRY; FACTUAL DATABASE; HUMAN; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

DATABASES, FACTUAL; HUMANS; NANOSTRUCTURES; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84926249662     PISSN: 1062936X     EISSN: 1029046X     Source Type: Journal    
DOI: 10.1080/1062936X.2014.993702     Document Type: Article

References (43)

1. I. Linkov and J. Steevens, NATO Advanced Research Workshop on Nanomaterials: Environmental Risks and Benefits, Springer, Dordrecht, 2009.
2. L. Lubinski, P. Urbaszek, A. Gajewicz, M. Cronin, S. Enoch, J. Madden, D. Leszczynska, J. Leszczynski, and T. Puzyn, Evaluation criteria for the quality of published experimental data on nanomaterials and their usefulness for QSAR modelling, SAR QSAR Environ. Res. 24 (2013), pp. 995–1008.10.1080/1062936X.2013.840679
3. E. Burello and A.P. Worth, QSAR modeling of nanomaterials, Nanomed. Nanobiotech. 3 (2011), pp. 298–306.
4. T. Puzyn and J. Leszczynski, Towards Efficient Designing of Safe Nanomaterials: Innovative Merge of Computational Approaches and Experimental Techniques, Royal Society of Chemistry, Cambridge, 2012.
5. D.A. Winkler, E. Mombelli, A. Pietroiusti, L. Tran, A. Worth, B. Fadeel, and M.J. McCall, Applying quantitative structure-activity relationship approaches to nanotoxicology: Current status and future potential, Toxicology (2012), pp. 15–23.
6. T. Puzyn, J. Leszczynski, and M.T. Cronin, Recent Advances in QSAR Studies: Methods and Applications, Challenges and Advances in Computational Chemistry and Physics 8, Springer, Dordrecht, 2010.10.1007/978-1-4020-9783-6
7. T. Puzyn, D. Leszczynska, and J. Leszczynski, Toward the development of “nano‐QSARs”: Advances and challenges, Small 5 (2009), pp. 2494–2509.10.1002/smll.v5:22
8. R. Tantra, C. Oksel, T. Puzyn, J. Wang, K.N. Robinson, X.Z. Wang, C.Y. Ma, and T. Wilkins, Nano (Q)SAR: Challenges, pitfalls and perspectives, Nanotoxicology (2014), pp. 1–7.10.3109/17435390.2014.952698
9. B. Fadeel, A. Pietroiusti, and A.A. Shvedova, Adverse Effects of Engineered Nanomaterials. Exposure, Toxicology, and Impact on Human Health, Academic Press, Waltham, MA, 2012.
10. D. Fourches, D. Pu, and A. Tropsha, Exploring quantitative nanostructure–activity relationships (QNAR) modeling as a tool for predicting biological effects of manufactured nanoparticles, Comb. Chem. High Throughput Screen. 14 (2011), pp. 217–225.10.2174/138620711794728743
11. P. Gedeck, B. Rohde, and C. Bartels, QSAR–how good is it in practice? Comparison of descriptor sets on an unbiased cross section of corporate data sets, J. Chem. Inf. Model. 46 (2006), pp. 1924–1936.10.1021/ci050413p
12. A. Poater, A.G. Saliner, M. Solà, L. Cavallo, and A.P. Worth, Computational methods to predict the reactivity of nanoparticles through structure–property relationships, Exp. Opin. Drug Deliv. 7 (2010), pp. 295–305.10.1517/17425240903508756
13. E. Burello and A. Worth, Computational nanotoxicology: Predicting toxicity of nanoparticles, Nat. Nanotechnol. 6 (2011), pp. 138–139.10.1038/nnano.2011.27
14. A. Gajewicz, B. Rasulev, T.C. Dinadayalane, P. Urbaszek, T. Puzyn, D. Leszczynska, and J. Leszczynski, Advancing risk assessment of engineered nanomaterials: Application of computational approaches, Adv. Drug. Deliv. Rev. (2012), pp. 1663–1693.
15. A.P. Toropova, A.A. Toropov, E. Benfenati, D. Leszczynska, and J. Leszczynski, QSAR modeling of measured binding affinity for fullerene-based HIV-1 PR inhibitors by CORAL, J. Math. Chem. 48 (2010), pp. 959–987.10.1007/s10910-010-9719-x
16. C. Sayes and I. Ivanov, Comparative study of predictive computational models for nanoparticle-induced cytotoxicity, Risk Anal. 30 (2010), pp. 1723–1734.10.1111/j.1539-6924.2010.01438.x
17. D. Fourches, D. Pu, C. Tassa, R. Weissleder, S.Y. Shaw, R.J. Mumper, and A. Tropsha, Quantitative nanostructure–activity relationship modeling, ACS Nano 4 (2010), pp. 5703–5712.10.1021/nn1013484
18. T. Puzyn, B. Rasulev, A. Gajewicz, X. Hu, T.P. Dasari, A. Michalkova, H.-M. Hwang, A. Toropov, D. Leszczynska, and J. Leszczynski, Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles, Nat. Nanotechnol. 6 (2011), pp. 175–178.10.1038/nnano.2011.10
19. Y.T. Chau and C.W. Yap, Quantitative nanostructure–activity relationship modelling of nanoparticles, RSC Advances 2 (2012), pp. 8489–8496.10.1039/c2ra21489j
20. H. Zhang, Z. Ji, T. Xia, H. Meng, C. Low-Kam, R. Liu, S. Pokhrel, S. Lin, X. Wang, and Y.-P. Liao, Use of metal oxide nanoparticle band gap to develop a predictive paradigm for oxidative stress and acute pulmonary inflammation, ACS Nano 6 (2012), pp. 4349–4368.10.1021/nn3010087
21. V.C. Epa, F.R. Burden, C. Tassa, R. Weissleder, S. Shaw, and D.A. Winkler, Modeling biological activities of nanoparticles, Nano Lett. 12 (2012), pp. 5808–5812.10.1021/nl303144k
22. M. Ghorbanzadeh, M.H. Fatemi, and M. Karimpour, Modeling the cellular uptake of magnetofluorescent nanoparticles in pancreatic cancer cells: A quantitative structure activity relationship study, Ind. Eng. Chem. Res. 51 (2012), pp. 10712–10718.10.1021/ie3006947
23. X.Z. Wang, Y. Yang, R.F. Li, C. McGuinnes, J. Adamson, I.L. Megson, and K. Donaldson, Principal component and causal analysis of structural and acute in vitro toxicity data for nanoparticles, Nanotoxicology 8 (2014), pp. 465–476.10.3109/17435390.2013.796534
24. R. Liu, R. Rallo, R. Weissleder, C. Tassa, S. Shaw, and Y. Cohen, Nano‐SAR development for bioactivity of nanoparticles with considerations of decision boundaries, Small (2013), pp. 1842–1852.10.1002/smll.201201903
25. R. Liu, H.Y. Zhang, Z.X. Ji, R. Rallo, T. Xia, C.H. Chang, A. Nel, and Y. Cohen, Development of structure–activity relationship for metal oxide nanoparticles, Nanoscale (2013), pp. 5644–5653.10.1039/c3nr01533e
26. C.-Y. Shao, S.-Z. Chen, B.-H. Su, Y.J. Tseng, E.X. Esposito, and A.J. Hopfinger, Dependence of QSAR models on the selection of trial descriptor sets: A demonstration using nanotoxicity endpoints of decorated nanotubes, J. Chem. Inf. Model. 53 (2013), pp. 142–158.10.1021/ci3005308
27. S. Kar, A. Gajewicz, T. Puzyn, and K. Roy, Nano-quantitative structure–activity relationship modeling using easily computable and interpretable descriptors for uptake of magnetofluorescent engineered nanoparticles in pancreatic cancer cells, Toxicol. In Vitro 28 (2014), pp. 600–606.10.1016/j.tiv.2013.12.018
28. D. Winkler, F. Burden, B. Yan, R. Weissleder, C. Tassa, S. Shaw, and V. Epa, Modelling and predicting the biological effects of nanomaterials, SAR QSAR Environ Res 25 (2014), pp. 161–172.10.1080/1062936X.2013.874367
29. R. Weissleder, K. Kelly, E.Y. Sun, T. Shtatland, and L. Josephson, Cell-specific targeting of nanoparticles by multivalent attachment of small molecules, Nat. Biotechnol. 23 (2005), pp. 1418–1423.10.1038/nbt1159
30. K.P. Singh and S. Gupta, Nano-QSAR modeling for predicting biological activity of diverse nanomaterials, RSC Advances 4 (2014), pp. 13215–13230.10.1039/c4ra01274g
31. A.A. Toropov, A.P. Toropova, T. Puzyn, E. Benfenati, G. Gini, D. Leszczynska, and J. Leszczynski, QSAR as a random event: Modeling of nanoparticles uptake in PaCa2 cancer cells, Chemosphere 92 (2013), pp. 31–37.10.1016/j.chemosphere.2013.03.012
32. S. Durdagi, T. Mavromoustakos, N. Chronakis, and M.G. Papadopoulos, Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations, Bioorg. Med. Chem. 16 (2008), pp. 9957–9974.10.1016/j.bmc.2008.10.039
33. A.A. Toropov, A.P. Toropova, E. Benfenati, D. Leszczynska, and J. Leszczynski, SMILES-based optimal descriptors: QSAR analysis of fullerene-based HIV-1 PR inhibitors by means of balance of correlations, J. Comput. Chem. 31 (2010), pp. 381–392.
34. S.Y. Shaw, E.C. Westly, M.J. Pittet, A. Subramanian, S.L. Schreiber, and R. Weissleder, Perturbational profiling of nanomaterial biologic activity, Proc. Natl. Acad. Sci. U. S. A., 105 (2008), pp. 7387–7392.10.1073/pnas.0802878105
35. H. Zhou, Q. Mu, N. Gao, A. Liu, Y. Xing, S. Gao, Q. Zhang, G. Qu, Y. Chen, and G. Liu, A nano-combinatorial library strategy for the discovery of nanotubes with reduced protein-binding, cytotoxicity, and immune response, Nano Lett. 8 (2008), pp. 859–865.10.1021/nl0730155
36. A.P. Toropova and A.A. Toropov, Optimal descriptor as a translator of eclectic information into the prediction of membrane damage by means of various TiO2 nanoparticles, Chemosphere 93 (2013), pp. 2650–2655.10.1016/j.chemosphere.2013.09.089
37. X. Hu, S. Cook, P. Wang, and H.-M. Hwang, In vitro evaluation of cytotoxicity of engineered metal oxide nanoparticles, Sci. Total Environ. 407 (2009), pp. 3070–3072.10.1016/j.scitotenv.2009.01.033
38. R. Liu, R. Rallo, S. George, Z. Ji, S. Nair, A.E. Nel, and Y. Cohen, Classification NanoSAR development for cytotoxicity of metal oxide nanoparticles, Small 7 (2011), pp. 1118–1126.10.1002/smll.201002366
39. D.G. Thomas, S. Gaheen, S.L. Harper, M. Fritts, F. Klaessig, E. Hahn-Dantona, D. Paik, S. Pan, G.A. Stafford, and E.T. Freund, ISA-TAB-nano: A specification for sharing nanomaterial research data in spreadsheet-based format, BMC Biotechnol. 13 (2013), p. 2.10.1186/1472-6750-13-2
40. S. Gaheen, caNanoLab Overview, Nanoinformatics, Arlington, VA, 2010.
41. M.L. Ostraat, K.C. Mills, K.A. Guzan, and D. Murry, The Nanomaterial Registry: Facilitating the sharing and analysis of data in the diverse nanomaterial community, Int. J. Nanomed. 8 (2013), p. 7.
42. O. Maimon and A. Browarnik, NHECD-Nano health and environmental commented database, in Data Mining and Knowledge Discovery Handbook, O.Z. Maimon and L. Rokach, eds., Springer, London and New York, 2010, pp. 1221–1241.10.1007/978-0-387-09823-4
43. S. Panneerselvam and S. Choi, Nanoinformatics: Emerging databases and available tools, Int. J. Mol. Sci. 15 (2014), pp. 7158–7182.10.3390/ijms15057158